Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction

Experimental and Clinical Transplantation

Volumn 8, Issue 4, 2010, Pages 277-282

  Khalkhali, Hamid Reza ^a   Ghafari, Ali ^b   Hajizadeh, Ebrahim ^a   Kazemnejad, Anoushirvan ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic allograft dysfunction; Renal transplantation; Survival

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGE; ARTICLE; BODY WEIGHT; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IRAN; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; RISK FACTOR; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; CHRONIC DISEASE; DELAYED GRAFT FUNCTION; DIABETES COMPLICATIONS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; IRAN; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 78650561663     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. http://www.worldkidneyday.org/the National Kidney and Transplant Institute.htm 2007.
2. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285-1295.
3. Shlipak MG, Fried LF, Stehman-Breen C, Siscovick D, Newman AB. Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study. Am J Geriatr Cardiol. 2004;13(2):81-90.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305. Erratum in: N Engl J Med. 2008;18(4):4.
5. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4(3):378-383.
6. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004;4(8):1289-1295.
7. Sayegh MH, Carpenter CB. Transplantation 50 years later--progress, challenges, and promises. N Engl J Med. 2004;351(26):2761-2766.
8. Keith DS, DeMattos A, Golconda M, Prather J, Cantarovich M, Paraskevas S, et al. Factors associated with improvement in deceased donor renal allograft function in the 1990s. J Am Soc Nephrol. 2005;16(5):1512-1521.
9. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347(2):103-109.
10. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol. 2005;16(10):3015-3026.
11. Paul LC. Chronic allograft nephropathy: An update. Kidney Int. 1999;56(3):783-793.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
13. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1-S266.
14. Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A. Risk factors for late kidney allograft failure. Kidney Int. 2002;62(5):1848-1854.
15. Lezaic V, Naumovic R, Marinkovic J, Jaksic E, Djukanovic L. Donor kidney glomerular filtration rate and posttransplant graft function. Am J Transplant. 2004;4(10):1669-1674.
16. Gurkan A, Tuncer M, Yücetin L, Colak T, Erdogan O, Demirbas A, et al. Effects of donor age on renal transplant outcome. Transplant Proc. 2002;34(6):2019-2020.
17. Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Transplantation. 2007;83(5):600-606.
18. Dickenmann MJ, Nickeleit V, Tsinalis D, Gürke L, Mihatsch MJ, Thiel G. Why do kidney grafts fail?A long-term single-center experience. Transpl Int. 2002;15(9-10):508-514.
19. Walker SR, Parsons DA, Coplestons P, Fenton SSA, Greig PD. The Canadian organ replacement register. In: Clinical Transplants, Cecka JM, Terasaki PI, eds. Los Angeles, UCLA Tissue Typing Laboratory; 1997:91-107.
20. Smits JMA, De Meester J, Persijn GG, Claas FHJ, Vanrenterghem Y: Long-term results of solid organ transplantation: Report from the Eurotransplant International Foundation. In: Clinical Transplants Cecka JM, Terasaki PI, eds. Los Angeles, UCLA Tissue Typing Laboratory; 1997:109-127.
21. Gjertson DW: A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS update. In: Clinical Transplants, Cecka JM, Terasaki PI, eds. Los Angeles, UCLA Tissue Typing Laboratory; 1997:343-360.
22. Johnston O, O'kelly P, Spencer S, Donohoe J, Walshe JJ, Little DM, et al. Reduced graft function (with or without dialysis) vs immediate graft function--a comparison of long-term renal allograft survival. Nephrol Dial Transplant. 2006;21(8):2270-2274.
23. Scolari MP, Cappuccilli ML, Lanci N, La Manna G, Comai G, Persici E, et al. Predictive factors in chronic allograft nephropathy. Transplant Proc. 2005;37(6):2482-2484.
24. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation. 1997;63(7):968-974.
25. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation. 1998;66(12):1697-1701.
26. Sijpkens Yvo WJ, Zwinderman AH, Mallat MJK, Boom H, Fijter JWde, Paul LC. Intercept and slope analysis of risk factors in chronic renal allograft nephropathy. Graft. 2002;5:108-113.
27. Gourishankar S, Hunsicker LG, Jhangri GS, Cockfield SM, Halloran PF. The stability of the glomerular filtration rate after renal transplantation is improving. J Am Soc Nephrol. 2003;14(9):2387-2394.
28. Gill JS, Tonelli M, Mix CH, Pereira BJ. The change in allograft function among long-term kidney transplant recipients. J Am Soc Nephrol. 2003;14(6):1636-1642.
29. Sancho A, Gavela E, Avila A, Morales A, Fernández-Nájera JE, Crespo JF, et al. Risk factors and prognosis for proteinuria in renal transplant recipients. Transplant Proc. 2007;39(7):2145-2147.
30. McLaren AJ, Fuggle SV, Welsh KI, Gray DW, Morris PJ. Chronic allograft failure in human renal transplantation: a multivariate risk factor analysis. Ann Surg. 2000;232(1):98-103.
31. Fernández-Fresnedo G, Plaza JJ, Sánchez-Plumed J, Sanz-Guajardo A, Palomar-Fontanet R, Arias M. Proteinuria: a new marker of longterm graft and patient survival in kidney transplantation. Nephrol Dial Transplant. 2004;19(suppl 3):iii47-iii51.
32. Kang NR, Lee JE, Huh W, Kim SJ, Kim YG, Kim DJ, et al. Minimal proteinuria one year after transplant is a risk factor for graft survival in kidney transplantation. J Korean Med Sci. 2009;24(suppl):S129-S134.
33. Roodnat JI, Mulder PG, Rischen-Vos J, van Riemsdijk IC, van Gelder T, Zietse R, et al. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation. 2001;72(3):438-444.
34. Fernández-Fresnedo G, Plaza JJ, Sánchez-Plumed J, Sanz-Guajardo A, Palomar-Fontanet R, et al. Proteinuria: a new marker of longterm graft and patient survival in kidney transplantation. Nephrol Dial Transplant. 2004;19(suppl 3):iii47-51.
35. Hohage H, Kleyer U, Brückner D, August C, Zidek W, Spieker C. Influence of proteinuria on long-term transplant survival in kidney transplant recipients. Nephron. 1997;75(2):160-165.
36. Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, McGill J, Mitch WE, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 2003;63(4):1499-1507.
37. Meier-Kriesche HU, Ojo AO, Cibrik DM, Hanson JA, Leichtman AB, Magee JC, et al. Relationship of recipient age and development of chronic allograft failure. Transplantation. 2000;70(2):306-310.